New Research: Predicting Year-End Medication Non-Adherence
Medication non-adherence is a significant challenge for all healthcare payers but, given its role in CMS Star Ratings, it bears particular weight for Medicare Part D plans.
In a new study, MedImpact evaluated the impact of using predictive data and technology to achieve early identification of members at risk for non-adherence. Read their findings.
PREDICTING YEAR-END MEDICATION NON-ADHERENCE
Authors: James Chamberlain, PharmD, MS; Laura Tidmore, PharmD, PhD1; Shellie Keast, PharmD, PhD; Jennifer Hendricks, PharmD, APh, BCACP, CDCES, FCPhA
This research is a meaningful step towards more proactive, predictive strategies that support better member outcomes–and improved Star Ratings performance.
Our team was selected by the Pharmacy Quality Alliance (PQA), a national quality organization dedicated to improving medication safety, adherence and appropriate use, to present this study at their Annual Meeting in May 2026. If you’re attending, be sure to stop by our poster and meet the team behind the research.
In today’s complex healthcare landscape, controlling costs and improving member health outcomes is more important than ever.
Government programs are growing more complex and harder to manage, often serving populations with higher health risks and costs.
Improving outcomes, controlling costs, and navigating evolving quality measures are ongoing challenges facing health plans.
Ready for a change?
